Medical research

New treatment prevents transplant rejection

A new treatment strategy could increase the success rate of stem cell transplants, according to University of Queensland researchers.

Diseases, Conditions, Syndromes

New histoplasmosis risk map

Histoplasmosis is a common lung infection caused by microscopic fungal spores that reside in soil. Most people who inhale the spores don't get sick, but for those with weakened immune systems, the infection can become severe. ...

Immunology

Can we get the immune system to tolerate organ transplants?

Currently, people receiving organ transplants must take drugs to suppress the inflammatory immune response that leads to rejection. Even so, almost all recipients eventually lose their transplant. A new approach, which maintains ...

Immunology

Immune-related adverse events up with checkpoint inhibitors

(HealthDay)—Although patients with pre-existing autoimmune disease who receive checkpoint inhibitors (CPIs) are at risk for exacerbation of their disease, immune-related adverse events (irAEs), or both, events can often ...

Diseases, Conditions, Syndromes

Immunosuppressant response predicts aplastic anemia survival

(HealthDay)—Response to immunosuppressive therapy (IST) predicts overall survival (OS) in aplastic anemia (AA), according to a study published online Aug. 29 in the American Journal of Hematology.

Diseases, Conditions, Syndromes

New study targets lethal fungal infection

The development of new drugs to fight a common fungal pathogen which kills half a million people globally each year is a step closer thanks to a University of Queensland-led study.

page 1 from 17